Population-based study of LAMA monotherapy effectiveness compared with LABA/LAMA as initial treatment for COPD in primary care

This epidemiological study aimed to describe and compare the characteristics and outcomes of COPD patients starting treatment with a long-acting anti-muscarinic (LAMA) or a combination of a long-acting beta-2 agonist (LABA)/LAMA in primary care in Catalonia (Spain) over a one-year period. Data were...

Descripción completa

Detalles Bibliográficos
Autores principales: Barrecheguren, Miriam, Monteagudo, Mónica, Miravitlles, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162319/
https://www.ncbi.nlm.nih.gov/pubmed/30266978
http://dx.doi.org/10.1038/s41533-018-0102-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162319/
https://www.ncbi.nlm.nih.gov/pubmed/30266978
http://dx.doi.org/10.1038/s41533-018-0102-x

Ejemplares similares